Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance

References

• Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–3082.
   PubMed Web of Science ®Google Scholar
• Sharifi F, Hajihosseini R, Mazloomi S, Amirmogaddami H, Nazem H. Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index. Metab Syndr Relat Disord 2010;8:47–52.
   PubMed Web of Science ®Google Scholar
• Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992;37:119–125.
   PubMed Web of Science ®Google Scholar
• Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002;106:286–288.
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 2000;52:595–600.
   PubMed Web of Science ®Google Scholar
• Cussons AJ, Stuckey BGA, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 2006;185:227–239.
   PubMed Web of Science ®Google Scholar
• Paolisso G, Scheen A, D'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990;33:511–514.
   PubMed Web of Science ®Google Scholar
• Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993;21:1024–1029.
   PubMed Web of Science ®Google Scholar
• Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid wall thickness: the ARIC study. J Clin Epidemiol 1985;48:927–940.
   Google Scholar
• Rosolova H, Mayer O Jr, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 2000;49:418–420.
   PubMed Web of Science ®Google Scholar
• Resnick LM, Gupta RK, Gruenspan H, Alderman MH, Laragh JH. Hypertension and peripheral insulin resistance: possible mediating role of intracellular free magnesium. Am J Hypertens 1990;3:373–379.
   PubMed Web of Science ®Google Scholar
• Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004;27:134–140.
   PubMed Web of Science ®Google Scholar
• Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151.
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Knauff EAH, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BCJM. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210–1217.
   PubMed Web of Science ®Google Scholar
• Meshkani R, Taghikhan M, , Larijani B, Khatami S, Khoshbin E, Adeli KH. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 2006;371:169–175.
   PubMed Web of Science ®Google Scholar
• Muneyyirci-Delale O, Nacharaju VL, Dalloul M, Jalou S, Rahman M, Altura BM, Altura BT. Divalent cations in women with PCOS: implications for cardiovascular disease. Gynecol Endocrinol 2001;15:198–201.
   PubMed Web of Science ®Google Scholar
• Kauffman RP, Tullar PE, Nipp RD, Castracane VD. Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome. Acta Obstet Gynecol Scand 2011;90:452–458.
   PubMed Web of Science ®Google Scholar
• Rabbani A, Alavian SM, Motlagh ME, Ashtiani MT, Ardalan G, Salavati A, Rabbani B, Rabbani A, Shams S, Parvaneh N. Vitamin D insufficiency among children and adolescents living in Tehran, Iran. J Trop Pediatr 2009;55:189–191.
   PubMed Web of Science ®Google Scholar
• Moussavi M, Heidarpour R, Aminorroaya A, Pournaghshband Z, Amini M. Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res 2005,64:144–148.
   PubMedGoogle Scholar
• Kazemi A, Sharifi F, Jafari N, Mousavinasab N: High prevalence of vitamin D deficiency among pregnant women and their newborns in an Iranian population. J Womens Health 2009;18:835–839.
   PubMed Web of Science ®Google Scholar
• Farhanghi MA, Mahboob S, Ostadrahimi A. induced magnesium deficiency can be treated by vitamin D supplementation. Pak Med Assoc 2009;59:258–261.
   PubMedGoogle Scholar
• Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF, Patrie JT, Rogol AD, Nadler JL. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175–1181.
   PubMed Web of Science ®Google Scholar
• Coudray C, Demigne C, Rayssiguier Y. Effects of dietary fibers on magnesium absorption in animals and humans. J Nutr 2003;133:1–4.
   PubMed Web of Science ®Google Scholar
• Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid wall thickness: the ARIC study. J Clin Epidemiol 1985;48:927–940.
   Google Scholar
• Rosolova H, Mayer O Jr, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 2000;49:418–420.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209–213.
   PubMed Web of Science ®Google Scholar
• Maltezos E, Papazoglou D, Exiara T, Kambouromiti G, Antonoglou C. Serum magnesium levels in non-diabetic offspring of patients with Type 2 diabetes mellitus. Diabetes Nutr Metab 2004;17:12–16.
   PubMedGoogle Scholar
• Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PW, Jacques PF: Magnesium intake is related to improved insulin homeostasis in the Framingham. J Am Coll Nutr 2006;25:486–492.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Rodríguez-Morán M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind,placebo-controlled clinical trial. J Hum Hypertens 2009;23:245–251.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, Rodríguez-Morán M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance: a double-blind placebo-controlled randomized trial. Diabetes Metab 2004;30:253–258.
   PubMed Web of Science ®Google Scholar
• Lee S, Park HK, Son SP, Lee CW, Kim IJ, Kim HJ. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis 2009;19:781–788.
   PubMed Web of Science ®Google Scholar
• Nadler JL, Rude RK. Disorders of magnesium metabolism. Endocrinol Metab Clin North Am 1995;24:623–641.
   PubMed Web of Science ®Google Scholar
• Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993;21:1024–1029.
   PubMed Web of Science ®Google Scholar
• Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude K. Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency. J Am Coll Nutr 1989;8:580–587.
   PubMed Web of Science ®Google Scholar
• Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010;93:1208–1214.
   PubMed Web of Science ®Google Scholar
• Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006;114:577–583.
   PubMed Web of Science ®Google Scholar
• Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, Kamaci M. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009;280:559–563.
   PubMed Web of Science ®Google Scholar